Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...

Prostate cancer resistant to hormone therapy could soon have a new treatment option. The Institute of Cancer Research (ICR), ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Sep. 4, 2024 — A treatment paradox has recently come to light in prostate cancer: blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay ...

A team from the Institute of Cancer Research, London, found NXP800 slowed the growth of prostate cancer cells, including ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.